IGF-1 LR3 (Long R3 IGF-1) is an engineered analog of insulin-like growth factor 1 carrying two defining modifications: an arginine substitution at position 3 and a 13-residue N-terminal extension. These deliberate changes turn a tightly regulated natural protein into a more persistent research reagent while preserving the core IGF-1 fold.
The R3 substitution
In native IGF-1, position 3 is a glutamate residue. Replacing it with arginine (the "R3" designation) markedly reduces the analog's affinity for the IGF-binding proteins that normally sequester circulating IGF-1. This single-residue swap is the primary driver of the altered behavior described in its mechanism of action.
The N-terminal extension
The "Long" prefix refers to a 13-amino-acid extension added to the N-terminus. This peptide tail further modifies binding-protein interactions and contributes to the molecule's stability in research media. Together, the extension and the R3 substitution shift the free-versus-bound equilibrium toward more available analog.
A larger recombinant protein
At roughly 83 residues, IGF-1 LR3 is substantially larger than most catalog peptides and includes internal disulfide bonds that define its tertiary structure. Molecules of this size and complexity are typically produced by recombinant expression in host cells rather than pure solid-phase synthesis, because assembling and correctly folding a protein of this length is impractical by stepwise chemistry alone. The concept of sequence-defined identity still applies — see understanding amino acid sequences.
Folding and disulfide formation
Correct biological identity depends on proper folding and the formation of the native disulfide bonds. Misfolded or scrambled-disulfide species have the same mass but different activity, so refolding and purification steps are integral to producing usable material.
Purification and quality control
The finished protein is purified, lyophilized (what is lyophilization), and confirmed by HPLC, with mass spectrometry verifying the expected molecular weight. Because folding matters as much as sequence, comparing methods as in HPLC vs. mass spectrometry is useful. For broader context, see the IGF-1 LR3 research overview.
Activity is not inferred from mass alone
A correct molecular mass confirms composition but cannot prove native-like folding, disulfide connectivity, or receptor activity. For a disulfide-rich growth factor, orthogonal characterization may include chromatographic comparison, intact-mass analysis, peptide mapping, and a cell-based receptor-response assay. Aggregates and incorrectly paired disulfide forms can be analytically subtle yet behave differently in culture. Production records also matter because host-cell proteins, nucleic acids, and process-related contaminants are distinct from peptide-sequence impurities. Together, chemical and functional tests provide a more complete identity profile than a single purity percentage and help researchers compare lots on scientifically meaningful grounds.
Product page: IGF-1 LR3 research vials.
Research Use Only. Supplied strictly for laboratory research and development — not for human or veterinary use, consumption, or any therapeutic or diagnostic purpose. This article is research education, not usage guidance.